Get started
Author

Mohammad Ismail

Observed names: Ismail, Mohammad, Mohammad Ismail Tajik
Observed institutions: Hayatabad Medical Complex, Government of Khyber Pakhtunkhwa, Iraqi University, University of Peshawar, Iraq University College, University of Technology Malaysia
ORCID: 0000-0001-7227-3399
Observed ORCID: 0000-0001-7227-3399
OpenAlex ID: A5100644881
Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
2020 · Mohammad Ismail, Sehrash Khan, et al. · BMC Cancer · 101
PDF
Potential drug–drug interactions in internal medicine wards in hospital setting in Pakistan
2013 · Mohammad Ismail, Zafar Iqbal, et al. · International Journal of Clinical Pharmacy · 58
Moxifloxacin-induced QT interval prolongation and torsades de pointes: a narrative review
2018 · Fahadullah Khan, Mohammad Ismail, et al. · Expert Opinion on Drug Safety · 47
Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study
2018 · Mohammad Ismail, Sidra Noor, et al. · BMC Health Services Research · 43
PDF
Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study
2017 · Mohammad Ismail, Sana Aziz, et al. · Journal of Critical Care · 40
Prevalence of the risk factors for QT prolongation and associated drug–drug interactions in a cohort of medical inpatients
2018 · Qasim Khan, Mohammad Ismail, et al. · Journal of the Formosan Medical Association · 32
PDF
Assessment of quality of life in post burn survivors: A cross-sectional single-center first validation study from Pakistan
2017 · Faiza Shahid, Mohammad Ismail, et al. · Burns Open · 30
PDF
Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
2019 · Sidra Noor, Mohammad Ismail, et al. · BMC Pharmacology and Toxicology · 29
PDF
Prevalence, types and predictors of potential drug-drug interactions in pulmonology ward of a tertiary care hospital
2011 · Mohammad Ismail · African Journal of Pharmacy and Pharmacology · 29
Prevalence of QT interval prolonging drug–drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study
2017 · Qasim Khan, Mohammad Ismail, et al. · International Journal of Clinical Pharmacy · 28
Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study
2023 · Zahid Ali, Mohammad Ismail, et al. · Scientific Reports · 25
PDF
Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study
2020 · Zahid Ali, Mohammad Ismail, et al. · BMC Psychiatry · 25
PDF
Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study
2017 · Qasim Khan, Mohammad Ismail, et al. · BMC Pharmacology and Toxicology · 24
PDF
Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system
2020 · Zahid Ali, Mohammad Ismail, et al. · Expert Opinion on Drug Safety · 22
Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety
2019 · Sidra Noor, Mohammad Ismail, et al. · Frontiers in Pharmacology · 21
PDF
QT interval prolongation in hospitalized patients on cardiology wards: a prospective observational study
2017 · Qasim Khan, Mohammad Ismail, et al. · European Journal of Clinical Pharmacology · 19
Potential drug–drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan
2016 · Mohammad Ismail, Farmanullah Khan, et al. · International Journal of Clinical Pharmacy · 18
High prevalence of the risk factors for QT interval prolongation and associated drug–drug interactions in coronary care units
2018 · Qasim Khan, Mohammad Ismail, et al. · Postgraduate Medicine · 17
Drug safety in hospitalized patients with tuberculosis: Drug interactions and adverse drug effects
2020 · Sidra Noor, Mohammad Ismail, et al. · The Clinical Respiratory Journal · 14
Potential drug–drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria
2020 · Sidra Noor, Mohammad Ismail, et al. · Malaria Journal · 13
PDF
Prevalence, predictors and outcomes of potential drug-drug interactions in left ventricular failure: considerable factors for quality use of medicines
2020 · Inamul Haq, Mohammad Ismail, et al. · Brazilian Journal of Pharmaceutical Sciences · 8
PDF
Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
2018 · Sidra Noor, Mohammad Ismail, et al. · Annals of Hepatology · 8
PDF
Perception and awareness of patients regarding ovarian cysts in Peshawar, Pakistan: A qualitative approach
2015 · Iffat Almas, Nisar-ur- Rehman, et al. · Współczesna Onkologia · 8
PDF
Increased burden of MDR bacterial infections; reflection from an antibiogram of ICUs of a tertiary care hospital
2023 · Jehan Zeb Khan, Mohammad Ismail, et al. · The Journal of Infection in Developing Countries · 6
PDF
Association of anxiolytic drugs with Torsade de Pointes: a pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System
2024 · Zahid Ali, Mohammad Ismail, et al. · Journal of Pharmaceutical Policy and Practice · 4
PDF
Works count: 35
Citation count: 683
H-index: 17
I10-index: 20
Year
Topic
Type